+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vascular Closure Device Market by Product Type, Procedure Type, Access Site, End User, Distribution Channel - Global Forecast to 2030- Product Image
Vascular Closure Device Market by Product Type, Procedure Type, Access Site, End User, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Vascular Closure Device Market by Product Type, Procedure Type, Access Site, End User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5460268
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Vascular Closure Device Market grew from USD 1.71 billion in 2024 to USD 1.85 billion in 2025. It is expected to continue growing at a CAGR of 7.54%, reaching USD 2.65 billion by 2030.

Shaping the Future of Vascular Closure Solutions

The vascular closure device market stands at a pivotal moment, driven by technological advances, regulatory evolutions, and shifting clinical practices. As healthcare systems worldwide prioritize patient safety, cost efficiency, and procedural efficacy, the demand for innovative closure solutions continues to accelerate. This analysis offers a concise yet comprehensive overview of the forces shaping this critical segment and lays the groundwork for strategic decision making.

In recent years, clinicians have sought alternatives to manual compression that reduce hemostasis time and enhance patient comfort. At the same time, device manufacturers have invested heavily in research and development, yielding a diverse array of products optimized for different procedures and access sites. This proliferation of solutions underscores the complexity of the market and the need for precise, data-driven insights.

Against this backdrop, stakeholders ranging from device developers and regulatory bodies to healthcare providers and payers must navigate an environment marked by rapid innovation and increasing cost pressures. This introduction sets the stage for a deep dive into transformative trends, regulatory impacts, segmentation dynamics, regional performance, and strategic imperatives, equipping decision makers with the clarity needed to chart a course forward.

Emerging Trends Redefining Vascular Closure

The landscape of vascular closure devices is undergoing profound shifts as emerging technologies and clinical needs converge. Biocompatible sealants and advanced plug materials are redefining safety profiles and hemostasis performance, while next-generation closure systems integrate real-time feedback mechanisms to support more consistent outcomes. Innovation in miniaturization and deployment techniques further streamlines procedures, enabling faster recovery times and lower complication rates.

Simultaneously, procedural paradigms are evolving. The shift toward radial access has gained momentum due to its association with reduced bleeding risks and improved patient mobility. This trend is transforming product design priorities and fueling demand for devices optimized for smaller diameter sheaths and delicate vascular structures. At the same time, the rise in minimally invasive interventions across cardiology and peripheral vascular applications is driving broader adoption of specialized closure solutions.

Transitional dynamics in reimbursement and hospital workflows are also shaping market direction. As value-based care models expand, providers seek devices that demonstrably lower overall procedure costs while preserving clinical quality. These transformative shifts underscore the necessity for stakeholders to align product innovation, clinical training, and strategic partnerships to capitalize on evolving opportunities.

Deconstructing the Effects of 2025 US Tariffs

The imposition of new tariffs by the United States government in 2025 introduces an additional layer of complexity to the vascular closure device market. Import fees on key components and finished devices are redefining cost structures for manufacturers and distributors alike. Companies reliant on offshore production now face increased landed costs, which in turn exert pressure on pricing negotiations with healthcare providers.

This tariff environment is compelling strategic realignments. Several manufacturers are accelerating localization efforts, establishing new production lines within North America to mitigate import duties and maintain competitive positioning. These moves involve significant capital investment but offer long-term resilience against policy volatility. Simultaneously, suppliers are reevaluating their global sourcing strategies, diversifying component procurement to balance cost optimization with supply chain reliability.

On the demand side, hospitals and clinics must adjust budgetary allocations as device expenditures inflate. Purchasing teams are intensifying value analysis processes, scrutinizing the total cost of ownership and exploring multi-year supplier agreements to stabilize pricing. While these adaptations introduce near-term uncertainty, they are also catalyzing closer collaboration between OEMs and end users. Stakeholders who proactively address tariff-induced challenges by reconfiguring supply chains and reinforcing service offerings will secure a sustainable advantage amid this policy-driven disruption.

Unpacking Market Segmentation Drivers

A detailed examination of market segmentation reveals nuanced patterns in device adoption and growth potential. Based on product type, clip based devices and suture based devices continue to hold substantial share thanks to their established clinical track record. Meanwhile, collagen plug devices have gained traction as surgeons gravitate toward enhanced hemostasis and reduced patient discomfort, with bovine collagen plugs favored for their bioactivity and synthetic variants prized for consistent performance. External compression devices remain relevant for low-risk procedures, but sealant based devices are carving out new niches, particularly those leveraging chitosan for its rapid clotting properties and polyethylene glycol for its biocompatible sealing characteristics.

When viewed through procedural lenses, diagnostic procedures such as angiographic studies and hemodynamic monitoring maintain steady demand, while interventional procedures in both cardiovascular and peripheral vascular domains are expanding rapidly. The latter’s growth is propelled by an aging population and rising prevalence of chronic vascular diseases, underscoring the need for closure devices that balance procedural efficiency with patient safety.

Access site segmentation further delineates market behavior: while femoral access remains dominant in complex interventions, radial access continues to expand across both diagnostic and interventional settings due to its favorable safety profile. In terms of end users, hospitals represent the largest volume purchasers, yet ambulatory surgical centers and clinics are emerging as pivotal growth drivers, attracted by the potential for streamlined workflows and lower overall costs. Finally, distribution channels underscore the importance of market reach; direct sales models offer closer customer engagement and bundled service offerings, whereas third party distributors provide extensive geographic coverage and logistical flexibility.

Regional Dynamics and Growth Hotspots

Geographic analysis illuminates distinct regional dynamics that shape competitive landscapes and investment priorities. In the Americas, a mature healthcare ecosystem underpinned by advanced procedural volumes and robust reimbursement frameworks sustains strong demand for premium closure solutions. Market participants here focus on differentiation through next-generation materials and integrated service models that streamline clinical workflows.

Across Europe, Middle East & Africa, the market reflects a patchwork of regulatory environments and reimbursement policies. Western Europe continues to adopt innovative technologies at a steady pace, while emerging economies in Eastern Europe and the Middle East present growth opportunities contingent on expanding healthcare infrastructure. Africa’s evolving medical frameworks signal long-term potential, particularly as governments increase spending on cardiovascular care.

In Asia-Pacific, rapid economic development and rising public health investments are fueling market expansion. Japan and Australia lead in procedural volumes and technology adoption, whereas China and India exhibit tremendous upside given their large patient populations and growing emphasis on cardiovascular interventions. Across the region, collaboration with local partners and adaptations to regional clinical practices are critical success factors for device manufacturers seeking to scale effectively.

Competitive Landscape and Strategic Players

The competitive landscape features a mix of global medical device giants and specialized innovators. Leading companies leverage extensive distribution networks, deep clinical trial pipelines, and diversified product portfolios to maintain market leadership. They invest heavily in R&D to refine deployment mechanisms, enhance biocompatibility, and introduce digital integrations that support procedural analytics and outcome tracking.

Simultaneously, a cohort of agile challengers focuses on niche opportunities. These firms differentiate through targeted product designs, such as ultra-low profile devices for pediatric interventions or novel bioactive formulations that expedite healing. Strategic collaborations and licensing agreements enable nimble players to access broader markets and accelerate time-to-market for breakthrough technologies. Collectively, the interplay between established players and emerging innovators drives continuous improvement and fosters a competitive environment that benefits end users.

Strategic Imperatives for Market Leaders

To navigate the complexities of the vascular closure device market, industry leaders must adopt a multi-pronged approach. First, advancing local manufacturing capabilities will mitigate tariff impacts and strengthen supply chain resilience. Second, deepening clinical partnerships and expanding training programs will drive adoption of next-generation closure solutions and build long-term loyalty with key healthcare institutions. Third, aligning product development roadmaps with evolving procedural trends-such as radial access and minimally invasive interventions-will ensure relevance and differentiation in a crowded market.

Moreover, companies should refine their value propositions by demonstrating total cost of ownership benefits and leveraging real-world evidence to support reimbursement discussions. Finally, strategic acquisitions and alliances can accelerate entry into high-growth segments and geographic markets. By integrating these initiatives, market leaders can secure sustainable growth, deliver meaningful clinical outcomes, and position themselves at the forefront of innovation.

Robust Methodology Underpinning Insights

This analysis draws upon a rigorous methodology designed to ensure accuracy, relevance, and actionable insight. Primary research included in-depth interviews with key opinion leaders, hospital procurement directors, and leading interventional cardiologists and radiologists. Secondary research encompassed extensive review of peer-reviewed literature, regulatory filings, clinical trial registries, and company disclosures.

Quantitative data was corroborated through cross-validation of multiple sources and reconciled to industry standards. Segmentation frameworks were developed based on product type, procedure type, access site, end-user category, and distribution channel, providing a robust foundation for granular insights. Regional dynamics were evaluated using a combination of macroeconomic indicators, healthcare expenditure trends, and procedural volume data.

Quality control processes included expert reviews and editorial audits to eliminate discrepancies and enhance clarity. Collectively, these methods ensure that the findings presented here reflect the most current and reliable intelligence available, empowering stakeholders to make informed strategic choices.

Concluding Perspectives on Vascular Closure Trends

The vascular closure device sector is poised for continued evolution as clinical, technological, and policy forces converge. Innovators who embrace material science breakthroughs, streamline procedural integration, and anticipate regulatory shifts will define the next chapter of market expansion. Meanwhile, supply chain optimization and strategic collaborations will prove indispensable in managing cost pressures and operational complexities.

Real-world evidence and outcome-focused product design will increasingly influence procurement decisions, reinforcing the need for transparent data and demonstrable value. Regional variances in adoption rates and reimbursement models highlight the importance of tailored market entry strategies, underpinned by local partnerships and context-specific product adaptations.

Ultimately, success in this dynamic field will hinge on agility, clinical credibility, and an unwavering commitment to patient-centered innovation. As stakeholders navigate a landscape reshaped by tariffs, evolving reimbursement frameworks, and shifting procedural preferences, the insights detailed here offer a roadmap for strategic alignment and sustained competitive advantage.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Clip Based Devices
    • Collagen Plug Devices
      • Bovine Collagen Plugs
      • Synthetic Collagen Plugs
    • External Compression Devices
    • Sealant Based Devices
      • Chitosan Sealants
      • Polyethylene Glycol Sealants
    • Suture Based Devices
  • Procedure Type
    • Diagnostic Procedures
      • Angiographic Procedures
      • Hemodynamic Monitoring
    • Interventional Procedures
      • Cardiovascular Interventions
      • Peripheral Vascular Interventions
  • Access Site
    • Femoral Access
    • Radial Access
  • End User
    • Ambulatory Surgical Centers
    • Clinics
    • Hospitals
  • Distribution Channel
    • Direct Sales
    • Third Party Distributors
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Abbott Laboratories
  • Terumo Corporation
  • Teleflex Incorporated
  • Cardinal Health, Inc.
  • Boston Scientific Corporation
  • Becton, Dickinson and Company
  • Merit Medical Systems, Inc.
  • B. Braun Melsungen AG
  • Cook Medical LLC
  • Lake Region Medical, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Vascular Closure Device Market, by Product Type
8.1. Introduction
8.2. Clip Based Devices
8.3. Collagen Plug Devices
8.3.1. Bovine Collagen Plugs
8.3.2. Synthetic Collagen Plugs
8.4. External Compression Devices
8.5. Sealant Based Devices
8.5.1. Chitosan Sealants
8.5.2. Polyethylene Glycol Sealants
8.6. Suture Based Devices
9. Vascular Closure Device Market, by Procedure Type
9.1. Introduction
9.2. Diagnostic Procedures
9.2.1. Angiographic Procedures
9.2.2. Hemodynamic Monitoring
9.3. Interventional Procedures
9.3.1. Cardiovascular Interventions
9.3.2. Peripheral Vascular Interventions
10. Vascular Closure Device Market, by Access Site
10.1. Introduction
10.2. Femoral Access
10.3. Radial Access
11. Vascular Closure Device Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Clinics
11.4. Hospitals
12. Vascular Closure Device Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Third Party Distributors
13. Americas Vascular Closure Device Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Vascular Closure Device Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Vascular Closure Device Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Abbott Laboratories
16.3.2. Terumo Corporation
16.3.3. Teleflex Incorporated
16.3.4. Cardinal Health, Inc.
16.3.5. Boston Scientific Corporation
16.3.6. Becton, Dickinson and Company
16.3.7. Merit Medical Systems, Inc.
16.3.8. B. Braun Melsungen AG
16.3.9. Cook Medical LLC
16.3.10. Lake Region Medical, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. VASCULAR CLOSURE DEVICE MARKET MULTI-CURRENCY
FIGURE 2. VASCULAR CLOSURE DEVICE MARKET MULTI-LANGUAGE
FIGURE 3. VASCULAR CLOSURE DEVICE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. VASCULAR CLOSURE DEVICE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. VASCULAR CLOSURE DEVICE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. VASCULAR CLOSURE DEVICE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLIP BASED DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY BOVINE COLLAGEN PLUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SYNTHETIC COLLAGEN PLUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY EXTERNAL COMPRESSION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CHITOSAN SEALANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY POLYETHYLENE GLYCOL SEALANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SUTURE BASED DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ANGIOGRAPHIC PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY HEMODYNAMIC MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CARDIOVASCULAR INTERVENTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR INTERVENTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY FEMORAL ACCESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY RADIAL ACCESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 57. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 58. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2030 (USD MILLION)
TABLE 59. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 60. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 61. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 62. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 63. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2030 (USD MILLION)
TABLE 64. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 67. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2030 (USD MILLION)
TABLE 68. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 69. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 70. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 71. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 72. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2030 (USD MILLION)
TABLE 73. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 106. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 107. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 108. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2030 (USD MILLION)
TABLE 110. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 113. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2030 (USD MILLION)
TABLE 114. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 115. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 116. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 117. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 118. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2030 (USD MILLION)
TABLE 119. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2030 (USD MILLION)
TABLE 123. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 124. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 125. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 126. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 127. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2030 (USD MILLION)
TABLE 128. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 131. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2030 (USD MILLION)
TABLE 132. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 133. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 134. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 135. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 136. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2030 (USD MILLION)
TABLE 137. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 140. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2030 (USD MILLION)
TABLE 141. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 142. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 143. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 144. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 145. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2030 (USD MILLION)
TABLE 146. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2030 (USD MILLION)
TABLE 150. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 151. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 152. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 153. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 154. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2030 (USD MILLION)
TABLE 155. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. UNITED ARAB EMIRATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 158. UNITED ARAB EMIRATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2030 (USD MILLION)
TABLE 159. UNITED ARAB EMIRATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 160. UNITED ARAB EMIRATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 161. UNITED ARAB EMIRATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 162. UNITED ARAB EMIRATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 163. UNITED ARAB EMIRATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2030 (USD MILLION)
TABLE 164. UNITED ARAB EMIRATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. UNITED ARAB EMIRATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. SAUDI ARABIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2030 (USD MILLION)
TABLE 168. SAUDI ARABIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 169. SAUDI ARABIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 170. SAUDI ARABIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 171. SAUDI ARABIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 172. SAUDI ARABIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2030 (USD MILLION)
TABLE 173. SAUDI ARABIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. SAUDI ARABIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. SOUTH AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 176. SOUTH AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2030 (USD MILLION)
TABLE 177. SOUTH AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 178. SOUTH AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 179. SOUTH AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 180. SOUTH AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 181. SOUTH AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2030 (USD MILLION)
TABLE 182. SOUTH AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. SOUTH AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. DENMARK VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 185. DENMARK VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2030 (USD MILLION)
TABLE 186. DENMARK VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 187. DENMARK VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 188. DENMARK VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 189. DENMARK VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 190. DENMARK VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2030 (USD MILLION)
TABLE 191. DENMARK VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. DENMARK VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 193. NETHERLANDS VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 194. NETHERLANDS VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2030 (USD MILLION)
TABLE 195. NETHERLANDS VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 202. QATAR VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 203. QATAR VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2030 (USD MILLION)
TABLE 204. QATAR VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 205. QATAR VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 206. QATAR VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 207. QATAR VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 208. QATAR VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2030 (USD MILLION)
TABLE 209. QATAR VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. QATAR VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 211. FINLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. FINLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2030 (USD MILLION)
TABLE 213. FINLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 214. FINLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 215. FINLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 216. FINLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 217. FINLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2030 (USD MILLION)
TABLE 218. FINLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. FINLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 220. SWEDEN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 221. SWEDEN VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2030 (USD MILLION)
TABLE 222. SWEDEN VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 223. SWEDEN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 224. SWEDEN VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 225. SWEDEN VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 226. SWEDEN VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2030 (USD MILLION)
TABLE 227. SWEDEN VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. SWEDEN VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. NIGERIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 230. NIGERIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2030 (USD MILLION)
TABLE 231. NIGERIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 232. NIGERIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 233. NIGERIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 234. NIGERIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 238. EGYPT VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 239. EGYPT VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2030 (USD MILLION)
TABLE 240. EGYPT VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 241. EGYPT VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 242. EGYPT VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 243. EGYPT VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 244. EGYPT VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2030 (USD MILLION)
TABLE 245. EGYPT VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. EGYPT VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 247. TURKEY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 248. TURKEY VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2030 (USD MILLION)
TABLE 249. TURKEY VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 250. TURKEY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 251. TURKEY VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 252. TURKEY VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 253. TURKEY VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2030 (USD MILLION)
TABLE 254. TURKEY VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. TURKEY VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 256. ISRAEL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 257. ISRAEL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2030 (USD MILLION)
TABLE 258. ISRAEL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 259. ISRAEL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 260. ISRAEL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 261. ISRAEL VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 262. ISRAEL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2030 (USD MILLION)
TABLE 263. ISRAEL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. ISRAEL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. NORWAY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 266. NORWAY VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2030 (USD MILLION)
TABLE 267. NORWAY VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 268. NORWAY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 269. NORWAY VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 270. NORWAY VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 271. NORWAY VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2030 (USD MILLION)
TABLE 272. NORWAY VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. NORWAY VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 274. POLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 275. POLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2030 (USD MILLION)
TABLE 276. POLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 277. POLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 278. POLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 279. POLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 280. POLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2030 (USD MILLION)
TABLE 281. POLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. POLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 283. SWITZERLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 284. SWITZERLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2030 (USD MILLION)
TABLE 285. SWITZERLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 286. SWITZERLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 287. SWITZERLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 288. SWITZERLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 289. SWITZERLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2030 (USD MILLION)
TABLE 290. SWITZERLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 291. SWITZERLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 292. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 293. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2030 (USD MILLION)
TABLE 294. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 295. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 296. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 297. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 298. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2030 (USD MILLION)
TABLE 299. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 301. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 302. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 303. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2030 (USD MILLION)
TABLE 304. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 305. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 306. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 307. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 308. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2030 (USD MILLION)
TABLE 309. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 310. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 311. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 312. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2030 (USD MILLION)
TABLE 313. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 314. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 315. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 316. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 3

Companies Mentioned

The companies profiled in this Vascular Closure Device market report include:
  • Abbott Laboratories
  • Terumo Corporation
  • Teleflex Incorporated
  • Cardinal Health, Inc.
  • Boston Scientific Corporation
  • Becton, Dickinson and Company
  • Merit Medical Systems, Inc.
  • B. Braun Melsungen AG
  • Cook Medical LLC
  • Lake Region Medical, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages189
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.85 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.65 Billion
Compound Annual Growth Rate7.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Vascular Closure Devices Market Size, Share & Trends Analysis Report by Product (Active Approximators, Passive Approximators), Application (Cardiac, Cerebrovascular), End-use, Region, and Segment Forecasts, 2025-2030 - Product Image

Vascular Closure Devices Market Size, Share & Trends Analysis Report by Product (Active Approximators, Passive Approximators), Application (Cardiac, Cerebrovascular), End-use, Region, and Segment Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
Vascular Closure Devices - Global Strategic Business Report - Product Image

Vascular Closure Devices - Global Strategic Business Report

  • Report
  • 477 Pages
  • Global
From
Vascular Closure Devices Market Report by Product, Access, Procedure, End-User, and Region 2025-2033 - Product Image

Vascular Closure Devices Market Report by Product, Access, Procedure, End-User, and Region 2025-2033

  • Report
  • 124 Pages
  • Global
From
Vascular Closure Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Vascular Closure Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Vascular Closure Devices Market Report 2025 - Product Image

Vascular Closure Devices Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Vascular Closure Device Market

The Vascular Closure Device (VCD) market is a segment of the Cardiovascular Devices industry. VCDs are used to close the puncture site of a vessel after a catheterization procedure. They are designed to reduce the risk of bleeding and hematoma formation, and to reduce the time required for the patient to recover. VCDs are typically made of biocompatible materials such as polymers, metals, and fabrics. VCDs are used in a variety of cardiovascular procedures, including angioplasty, stenting, and atherectomy. They are also used in the treatment of peripheral artery disease, coronary artery disease, and other cardiovascular conditions. The VCD market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include Abbott, Medtronic, Terumo, Merit Medical, and Boston Scientific. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.